DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» VEGFR1
VEGFR1
The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling In
Ret Oncogene and Thyroid Carcinoma
Serum Levels of VEGF and MCSF in HER2+ / HER2- Breast Cancer Patients with Metronomic Neoadjuvant Chemotherapy Roberto J
Regulation of Vascular Endothelial Growth Factor Receptor-1 Expression by Specificity Proteins 1, 3, and 4In Pancreatic Cancer Cells
Moguntinones—New Selective Inhibitors for the Treatment of Human Colorectal Cancer
Unveiling the Molecular Mechanisms Regulating the Activation of the Erbb Family Receptors at Atomic Resolution Through Molecular Modeling and Simulations
Dual Inhibition Using Cabozantinib Overcomes HGF/MET Signaling Mediated Resistance to Pan-VEGFR Inhibition in Orthotopic and Metastatic Neuroblastoma Tumors
Vascular Endothelial Growth Factor (VEGF) Signaling in Tumor Progression Robert Roskoski Jr
Heparin-Binding VEGFR1 Variants As Long-Acting VEGF Inhibitors for Treatment of Intraocular Neovascular Disorders
RET: a Multi-Faceted Gene in Human Cancer
Novel Targeted Agents for the Treatment of Bladder Cancer: Translating Laboratory Advances Into Clinical Application
Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
Role of Vegfs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
VEGF-B VEGF-B Also Called VEGF-Related Factor/VRF
Blockade of Epha Receptor Tyrosine Kinase Activation Inhibits Vascular Endothelial Cell Growth Factor-Induced Angiogenesis
Autocrine VEGF/VEGFR1 Signaling in a Subpopulation of Cells Associates with Aggressive Osteosarcoma
Recombinant Mouse VEGFR1/Flt-1 Fc Chimera Catalog Number: 471-F1
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor
Top View
Differential Expression of VEGFR2 Protein in HER2 Positive Primary
The Prognostic and Predictive Value of Mrna Expression of Vascular
New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer
Influence of RET Mutations on the Expression of Tyrosine Kinases In
Inhibition of Vascular Endothelial Growth Factor Reduces Angiogenesis and Modulates Immune Cell Infiltration of Orthotopic Breast Cancer Xenografts
Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy
A Novel Inhibitor of C-Met and VEGF Receptor Tyrosine Kinases with a Broad
Glycosylation As a Main Regulator of Growth and Death Factor Receptors Signaling
VEGFR1 Rabbit Pab
Exploring the Intracrine Functions of VEGF-A
Binding of VEGF-A to Canine Cancer Cells with Preferential Expression of VEGFR1
The Role of Heterodimerization Between VEGFR-1 and VEGFR-2 in the Regulation of Endothelial Cell Homeostasis
Expression of the VEGF-A/VEGFR1/VEGFR2 Signature Genes: Potential New Diagnostic and Prognostic Molecular Markers in Patients with Myelodysplastic Syndromes (MDS)
Heparin-Binding VEGFR1 Variants As Long-Acting VEGF Inhibitors for Treatment of Intraocular Neovascular Disorders
Pericytes Regulate VEGF-Induced Endothelial Sprouting Through VEGFR1
Human VEGFR1 ELISA Kit Target Protein Species: Human Range 156 Pg/Ml – 10Ng/Ml Cat
Research Progress of Small Molecule VEGFR/C-Met Inhibitors As Anticancer Agents (2016–Present)
Eph Signaling in Vascular Development Thesis by Sebastian
Novel Therapeutic Inhibitors of the C-Met Signaling Pathway in Cancer Joseph Paul Eder,1George F
VEGF-Dependent Tumor Angiogenesis Requires Inverse and Reciprocal Regulation of VEGFR1 and VEGFR2
VEGFR1 Signaling in Retinal Angiogenesis and Microinflammation
Tumor Angiogenesis Revisited: Regulators and Clinical Implications
Combined Blockade of HER2 and VEGF Exerts Greater Growth Inhibition of HER2-Overexpressing Gastric Cancer Xenografts Than Individual Blockade
Mouse FLT1,VEGFR1 ELISA Kit
Cluster of Differentiation Antigen 135; CD135; Fms Like Tyrosine Kinase 3
C-MET Inhibition: Novel Treatment for Sporadic and MEN1-Associated GEP Nets
Vascular Endothelial Growth Factor Signaling in Development and Disease Sinem Karaman*, Veli-Matti Leppänen* and Kari Alitalo‡
Haematopoietic Focal Adhesion Kinase Deficiency Alters Haematopoietic
Inhibition of Oncogenic Kinases: an in Vitro Validated Computational Approach Identified Potential Multi- Target Anticancer Compounds
Influence of RET Mutations on the Expression of Tyrosine Kinases In
Pharmacological Research Role of RET Protein-Tyrosine Kinase
Targeting Promiscuous Heterodimerization Overcomes Innate Resistance to ERBB2 Dimerization Inhibitors in Breast Cancer Sean P
Head, Neck, and Thyroid Cancer
CD135;Fms Like Tyrosine Kinase 3
Proximal Domains Are Required for VEGF Receptor Activation and Cell Signaling
VEGFR1 Expression Is Related to Lymph Node Metastasis and Serum
Predictive Immunohistochemical Markers Related to Drug Selection
Ligand-Induced Downregulation of the Kinase-Dead Ephb6 Receptor
Semaphorin Receptors Meet Receptor Tyrosine Kinases on the Way of Tumor Progression
HHEX Is a Transcriptional Regulator of the VEGFC/FLT4/PROX1 Signaling Axis During Vascular Development
Gene Symbol AATYK AATYK2 AATYK3 ALK AXL CSF1R DDR1
Sunitinib: a VEGF and PDGF Receptor Protein Kinase and Angiogenesis Inhibitor